SEC Form D private-offering filing

Fairfield Bio, Inc.

Name: Fairfield Bio, Inc. - new SEC Form D private-offering filing, Bronx, NY
Published: 2026-02-12

A new SEC Form D private-offering notice from Bronx, NY, a $2,000,000 filer-stated offering target in Biotech. The source filing is one click away.

Fairfield Bio, Inc. site↗ Verified via SEC Form D

Operates a marketplace connecting non-human genomic data providers with researchers and commercial users, using contractual data sharing terms.

Filed 2026-02-12Filed to raise $2,000,000First money in 2026-01-26Raised so far $450,000HQ (as filed) Bronx, NYSector Biotech ✓Stage (inferred) SeedCall status Call-ready

Source linked the Form D on EDGAR↗Website verified fairfieldbio.com↗Named in the filing 2 executives & directors

Open this row on the live feed →More new filings in New York →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.